These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 35497215)
1. Photosensitizer-loaded cell membrane biomimetic nanoparticles for enhanced tumor synergetic targeted therapy. Zhang Y; Ma N; Luo C; Zhu J; Bao C RSC Adv; 2020 Mar; 10(16):9378-9386. PubMed ID: 35497215 [TBL] [Abstract][Full Text] [Related]
2. Polylactide-Based Block Copolymeric Micelles Loaded with Chlorin e6 for Photodynamic Therapy: In Vitro Evaluation in Monolayer and 3D Spheroid Models. Kumari P; Jain S; Ghosh B; Zorin V; Biswas S Mol Pharm; 2017 Nov; 14(11):3789-3800. PubMed ID: 28969421 [TBL] [Abstract][Full Text] [Related]
3. Nano-delivery vehicle based on chlorin E6, photodynamic therapy, doxorubicin chemotherapy provides targeted treatment of HER-2 negative, ανβ3-positive breast cancer. He Z; Jiang H; Zhang X; Zhang H; Cui Z; Sun L; Li H; Qian J; Ma J; Huang J Pharmacol Res; 2020 Oct; 160():105184. PubMed ID: 32946931 [TBL] [Abstract][Full Text] [Related]
4. Red blood cell membrane-camouflaged nanoparticles: a novel drug delivery system for antitumor application. Xia Q; Zhang Y; Li Z; Hou X; Feng N Acta Pharm Sin B; 2019 Jul; 9(4):675-689. PubMed ID: 31384529 [TBL] [Abstract][Full Text] [Related]
5. A Redox-Activatable and Targeted Photosensitizing Agent to Deliver Doxorubicin for Combining Chemotherapy and Photodynamic Therapy. Yin J; Ouyang C; Shen S; Zhou Y; He G; Zhang H; Zhou K; Chen G; Ren L Mol Pharm; 2022 Jul; 19(7):2441-2455. PubMed ID: 35616274 [TBL] [Abstract][Full Text] [Related]
6. Doxorubicin-loaded pH-responsive nanoparticles coated with chlorin e6 for drug delivery and synergetic chemo-photodynamic therapy. Liang J; Jin X; Chen B; Hu J; Huang Q; Wan J; Hu Z; Wang B Nanotechnology; 2020 May; 31(19):195103. PubMed ID: 31978912 [TBL] [Abstract][Full Text] [Related]
7. Photodynamic Treatment of Colorectal Cancer Using Chlorin e6-Loaded Poly(lactide-co-glycolide)- Based Nanoparticles. Lin B; Xu X; Zhang X; Yu Y; Wang X J Biomed Nanotechnol; 2021 Oct; 17(10):1939-1950. PubMed ID: 34706794 [TBL] [Abstract][Full Text] [Related]
8. Oxygen self-enriched nanoparticles functionalized with erythrocyte membranes for long circulation and enhanced phototherapy. Ren H; Liu J; Li Y; Wang H; Ge S; Yuan A; Hu Y; Wu J Acta Biomater; 2017 Sep; 59():269-282. PubMed ID: 28663143 [TBL] [Abstract][Full Text] [Related]
9. Folic acid-modified bovine serum albumin nanoparticles with doxorubicin and chlorin e6 for effective combinational chemo-photodynamic therapy. Lee H; Kim S; Oh C; Khan I; Shukla S; Bajpai VK; Han YK; Huh YS Mater Sci Eng C Mater Biol Appl; 2020 Dec; 117():111343. PubMed ID: 32919690 [TBL] [Abstract][Full Text] [Related]
10. Reactive Oxygen Species and Folate Receptor-Targeted Nanophotosensitizers Composed of Folic Acid-Conjugated and Poly(ethylene glycol)-Chlorin e6 Tetramer Having Diselenide Linkages for Targeted Photodynamic Treatment of Cancer Cells. Yang SW; Jeong YI; Kook MS; Kim BH Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328538 [TBL] [Abstract][Full Text] [Related]
11. Nanoceria-Mediated Drug Delivery for Targeted Photodynamic Therapy on Drug-Resistant Breast Cancer. Li H; Liu C; Zeng YP; Hao YH; Huang JW; Yang ZY; Li R ACS Appl Mater Interfaces; 2016 Nov; 8(46):31510-31523. PubMed ID: 27933980 [TBL] [Abstract][Full Text] [Related]
12. Supramolecular micelles as multifunctional theranostic agents for synergistic photodynamic therapy and hypoxia-activated chemotherapy. Huang X; Chen T; Mu N; Lam HW; Sun C; Yue L; Cheng Q; Gao C; Yuan Z; Wang R Acta Biomater; 2021 Sep; 131():483-492. PubMed ID: 34265471 [TBL] [Abstract][Full Text] [Related]
13. Targeted co-delivery of a photosensitizer and an antisense oligonucleotide based on an activatable hyaluronic acid nanosystem with endogenous oxygen generation for enhanced photodynamic therapy of hypoxic tumors. Wu Y; Ding L; Zheng C; Li H; Wu M; Sun Y; Liu X; Zhang X; Zeng Y Acta Biomater; 2022 Nov; 153():419-430. PubMed ID: 36115655 [TBL] [Abstract][Full Text] [Related]
14. Comparative study of photosensitizer loaded and conjugated glycol chitosan nanoparticles for cancer therapy. Lee SJ; Koo H; Jeong H; Huh MS; Choi Y; Jeong SY; Byun Y; Choi K; Kim K; Kwon IC J Control Release; 2011 May; 152(1):21-9. PubMed ID: 21457740 [TBL] [Abstract][Full Text] [Related]
15. Efficient Delivery of Chlorin e6 by Polyglycerol-Coated Iron Oxide Nanoparticles with Conjugated Doxorubicin for Enhanced Photodynamic Therapy of Melanoma. Li TF; Xu HZ; Xu YH; Yu TT; Tang JM; Li K; Wang C; Peng XC; Li QR; Sang XY; Zheng MY; Liu Y; Zhao L; Chen X Mol Pharm; 2021 Sep; 18(9):3601-3615. PubMed ID: 34388342 [TBL] [Abstract][Full Text] [Related]
16. Oxygen-producing catalase-based prodrug nanoparticles overcoming resistance in hypoxia-mediated chemo-photodynamic therapy. Cheng X; He L; Xu J; Fang Q; Yang L; Xue Y; Wang X; Tang R Acta Biomater; 2020 Aug; 112():234-249. PubMed ID: 32502633 [TBL] [Abstract][Full Text] [Related]
17. Development of chlorin e6-conjugated poly(ethylene glycol)-poly(d,l-lactide) nanoparticles for photodynamic therapy. Kumari P; Rompicharla SVK; Bhatt H; Ghosh B; Biswas S Nanomedicine (Lond); 2019 Apr; 14(7):819-834. PubMed ID: 30874479 [TBL] [Abstract][Full Text] [Related]
18. Targeted photodynamic therapy of glioblastoma mediated by platelets with photo-controlled release property. Xu HZ; Li TF; Ma Y; Li K; Zhang Q; Xu YH; Zhang YC; Zhao L; Chen X Biomaterials; 2022 Nov; 290():121833. PubMed ID: 36201945 [TBL] [Abstract][Full Text] [Related]
19. PEG-functionalized iron oxide nanoclusters loaded with chlorin e6 for targeted, NIR light induced, photodynamic therapy. Li Z; Wang C; Cheng L; Gong H; Yin S; Gong Q; Li Y; Liu Z Biomaterials; 2013 Dec; 34(36):9160-70. PubMed ID: 24008045 [TBL] [Abstract][Full Text] [Related]
20. Dual Effect of Chemo-PDT with Tumor Targeting Nanoparticles Containing iRGD Peptide. Kim GL; Park B; Jang EH; Gu J; Seo SR; Cheung H; Lee HJ; Lee S; Kim JH Pharmaceutics; 2023 Feb; 15(2):. PubMed ID: 36839936 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]